MRL Ventures Fund LLC 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 4:57 pm Purchase | 2023-03-30 | 13G | Xilio Therapeutics, Inc. XLO | MRL Ventures Fund LLC | 1,483,414 5.400% | 1,483,414 (New Position) | Filing |